TipRanks
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
INM
InMed Pharmaceuticals
RESEARCH TOOLSreports
Want to see INM full AI Analyst Report?

InMed Pharmaceuticals (INM) Income Statement

396 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q4 2026), InMed Pharmaceuticals's total revenue was C$2.06B, an increase of 115691.64% from the same quarter last year. In Q4, InMed Pharmaceuticals's net income was C$-5.08M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
$ 3.18B$ 4.94M$ 4.60M$ 4.14M$ 1.09M
Gross Profit
$ 709.84M$ 1.71M$ 1.10M$ 1.40M$ 543.55K
Operating Expenses
$ 9.19M$ 9.62M$ 9.24M$ 9.78M$ 14.34M
Depreciation and Amortization
$ 708.36K$ 534.73K$ 604.52K$ 596.00K$ 511.79K
EBITDA
$ -9.19M$ -7.26M$ -7.06M$ -7.34M$ -18.09M
Operating Income
$ -9.90M$ -7.92M$ -8.13M$ -8.38M$ -13.79M
Other Income/Expenses
$ -1.48M$ -244.14K$ 465.98K$ 444.26K$ -4.81M
Pretax Income
$ -11.37M$ -8.16M$ -7.67M$ -7.93M$ -18.60M
Net Income
$ -12.56M$ -8.16M$ -7.68M$ -7.95M$ -18.60M
Per Share Metrics
Basic EPS
$ -3.12$ -8.36$ -20.14$ -64.92$ -16.58K
Diluted EPS
$ -3.12$ -8.36$ -20.14$ -64.92$ -16.58K
Weighted Average Shares Outstanding
 4.16M 975.99K 381.05K 122.42K 1.12K
Weighted Average Shares Outstanding (Diluted)
 4.16M 975.99K 381.05K 122.42K 1.12K

InMed Pharmaceuticals Earnings and Revenue History